2月24日 - ** 生物技术公司Werewolf Therapeutics HOWL.O的股价在盘后交易中上涨7.3%至71美分
** 该公司称将探索各种战略选择，以推进其药物开发管线
** 公司称，"措施可能包括出售公司、业务合并或兼并、出售资产、许可或合作安排或其他战略交易"。
** 公司表示没有明确的审查时间表
** 公司已聘请 Piper Sandler & Co 担任财务顾问
** 2025 年股价上涨 57.2%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.